Charles Schwab Investment Management Inc Vera Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 361,805 shares of VERA stock, worth $15.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
361,805
Previous 351,088
3.05%
Holding current value
$15.4 Million
Previous $12.7 Million
25.87%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding VERA
# of Institutions
184Shares Held
55.1MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$184 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$168 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$142 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$126 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$119 Million11.68% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.15B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...